迴天新材(300041.SZ):擬斥1億元-2億元回購公司股份
格隆匯3月20日丨迴天新材(300041.SZ)公佈關於回購公司股份方案(第三期)的公吿,公司擬使用自有資金以集中競價交易方式回購公司部分人民幣普通A股股份,用於實施股權激勵計劃及/或員工持股計劃。此次回購總金額不低於人民幣1億元(含)且不超過人民幣2億元(含),回購價格為不超過人民幣16.00元/股(含),回購股份的實施期限為自公司董事會審議通過此次回購方案之日起不超過12個月。
在回購價格上限16.00元/股(含)的條件下,此次預計回購股份總數為6,250,000股至12,500,000股,約佔公司總股本的比例為1.45%至2.90%,具體回購股份的數量以回購期滿時實際回購的股份數量為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.